Skip to content

Sustainability of antiretroviral therapy in HIV-infected adult urban Kenyans: lessons for other resource-poor countries

Frequent switchers have lower quality of life, higher suicidality

Booster therapy after starting HIV treatment may offer way of reducing long-term drug burden

Is what we know about transmitted drug resistance just ‘the tip of the iceberg?’

Treatment failure and drug resistance not associated with rapid death or illness in Côte d’Ivoire study

Darunavir superior to lopinavir in 48-week study in treatment-experienced patients

TMC-125 and darunavir show strong effect in highly treatment-experienced, even without T-20

Thai programme demonstrates HIV services can be successfully delivered in prison

Brazil: Kaletra price cut agreed as generic efavirenz arrives